2021 Q4 Form 10-Q Financial Statement

#000180116921000120 Filed on November 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q4
Revenue $3.822B $2.266B $248.9M
YoY Change 1435.64% 569.31% -80.18%
Cost Of Revenue $3.550B $2.064B $210.5M
YoY Change 1586.64% 581.59% -82.19%
Gross Profit $271.6M $202.5M $38.37M
YoY Change 607.96% 465.44% -48.13%
Gross Profit Margin 7.11% 8.93% 15.41%
Selling, General & Admin $342.1M $243.6M $92.10M
YoY Change 271.46% 260.87% -26.73%
% of Gross Profit 125.96% 120.3% 240.06%
Research & Development $31.84M $27.30M $12.40M
YoY Change 156.77% 107.03% -11.43%
% of Gross Profit 11.72% 13.48% 32.32%
Depreciation & Amortization $20.45M $7.200M $7.500M
YoY Change 172.65% 18.03% -15.73%
% of Gross Profit 7.53% 3.56% 19.55%
Operating Expenses $374.0M $270.9M $104.5M
YoY Change 257.85% 235.73% -25.2%
Operating Profit -$102.3M -$68.41M -$66.13M
YoY Change 54.75% 52.43% 0.6%
Interest Expense -$72.80M $43.55M -$11.10M
YoY Change 555.89% 251.89% -61.72%
% of Operating Profit
Other Income/Expense, Net -$15.60M $51.97M $700.0K
YoY Change -2328.71% 6701.7% -76.67%
Pretax Income -$190.6M -$56.49M -$88.00M
YoY Change 116.53% -30.1% -4.14%
Income Tax $390.0K $300.0K -$200.0K
% Of Pretax Income
Net Earnings -$190.9M -$56.82M -$87.79M
YoY Change 117.49% -29.73% -4.28%
Net Earnings / Revenue -5.0% -2.51% -35.27%
Basic Earnings Per Share -$0.09 -$0.49
Diluted Earnings Per Share -$311.6K -$0.09 -$0.49
COMMON SHARES
Basic Shares Outstanding 612.6M shares 603.4M shares
Diluted Shares Outstanding 603.4M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.215B $1.840B $1.461B
YoY Change 51.65% 233.6% 225.62%
Cash & Equivalents $1.731B $1.359B $1.413B
Short-Term Investments $484.0M $481.1M $47.64M
Other Short-Term Assets $91.00M $84.37M $24.00M
YoY Change 279.17% -58.6% -22.28%
Inventory $6.096B $6.268B $465.9M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $9.340B $8.821B $2.053B
YoY Change 354.94% 855.17% -1.66%
LONG-TERM ASSETS
Property, Plant & Equipment $45.00M $38.32M $29.00M
YoY Change 55.17% -52.86% -16.2%
Goodwill $60.00M $47.16M $31.00M
YoY Change 93.55% 0.18%
Intangibles $12.00M $11.49M $9.000M
YoY Change 33.33% -27.5%
Long-Term Investments
YoY Change
Other Assets $7.000M $6.842M $4.000M
YoY Change 75.0% 62.9% -25.84%
Total Long-Term Assets $166.0M $147.6M $123.0M
YoY Change 34.96% 17.43% -14.61%
TOTAL ASSETS
Total Short-Term Assets $9.340B $8.821B $2.053B
Total Long-Term Assets $166.0M $147.6M $123.0M
Total Assets $9.506B $8.969B $2.176B
YoY Change 336.86% 754.81% -2.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.000M $156.0M $2.800M
YoY Change 7.14% 4775.94%
Accrued Expenses $66.00M $14.38M $11.00M
YoY Change 500.0% -68.04% -32.69%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $4.247B $4.070B $346.3M
YoY Change 1126.32% 3238.42% -67.76%
Total Short-Term Liabilities $4.400B $4.240B $393.0M
YoY Change 1019.59% 2268.69% -65.11%
LONG-TERM LIABILITIES
Long-Term Debt $2.816B $2.320B $135.5M
YoY Change 1978.23% 1457.32%
Other Long-Term Liabilities $42.00M $2.324M $94.00K
YoY Change 44580.85% -95.19% -54.81%
Total Long-Term Liabilities $2.858B $2.324M $94.00K
YoY Change 3040325.53% -98.82% -54.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.400B $4.240B $393.0M
Total Long-Term Liabilities $2.858B $2.324M $94.00K
Total Liabilities $7.258B $6.606B $623.0M
YoY Change 1065.01% 1655.45% -60.65%
SHAREHOLDERS EQUITY
Retained Earnings -$1.705B -$1.515B -$1.043B
YoY Change 63.47% 31.94%
Common Stock $0.00 $60.00K $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.248B $2.363B $1.600B
YoY Change
Total Liabilities & Shareholders Equity $9.506B $8.969B $2.176B
YoY Change 336.86% 754.81% -2.5%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q4
OPERATING ACTIVITIES
Net Income -$190.9M -$56.82M -$87.79M
YoY Change 117.49% -29.73% -4.28%
Depreciation, Depletion And Amortization $20.45M $7.200M $7.500M
YoY Change 172.65% 18.03% -15.73%
Cash From Operating Activities $109.6M -$3.591B -$355.5M
YoY Change -130.82% -446.2% -973.46%
INVESTING ACTIVITIES
Capital Expenditures -$10.33M -$12.47M -$5.200M
YoY Change 98.69% 3.07% -16.13%
Acquisitions
YoY Change
Other Investing Activities -$33.84M -$245.3M $34.30M
YoY Change -198.67% 532.3% -468.82%
Cash From Investing Activities -$44.18M -$257.8M $28.90M
YoY Change -252.85% 407.48% -286.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 668.9M 4.003B 1.189B
YoY Change -43.72% -489.48% 31176.32%
NET CHANGE
Cash From Operating Activities 109.6M -3.591B -355.5M
Cash From Investing Activities -44.18M -257.8M 28.90M
Cash From Financing Activities 668.9M 4.003B 1.189B
Net Change In Cash 734.3M 153.8M 861.9M
YoY Change -14.81% -473.26% 2872.07%
FREE CASH FLOW
Cash From Operating Activities $109.6M -$3.591B -$355.5M
Capital Expenditures -$10.33M -$12.47M -$5.200M
Free Cash Flow $119.9M -$3.579B -$350.3M
YoY Change -134.22% -441.02% -846.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001801169
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
open Class Of Warrant Or Right Trading Day Period Used To Determine Reference Value On The Last Reported Sales Price Of Common Stock
ClassOfWarrantOrRightTradingDayPeriodUsedToDetermineReferenceValueOnTheLastReportedSalesPriceOfCommonStock
P30D
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39253
dei Entity Registrant Name
EntityRegistrantName
Opendoor Technologies Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1515020
dei Entity Address Address Line1
EntityAddressAddressLine1
410 N. Scottsdale Road,
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1600
dei Entity Address City Or Town
EntityAddressCityOrTown
Tempe,
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85281
dei City Area Code
CityAreaCode
415
dei Local Phone Number
LocalPhoneNumber
896-6737
dei Security12b Title
Security12bTitle
Common stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
OPEN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
612612711 shares
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1358775000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1412665000 USD
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
484476000 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
92863000 USD
CY2021Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
481051000 USD
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
47637000 USD
CY2021Q3 us-gaap Pledged Assets Separately Reported Mortgage Related Securities Available For Sale Or Held For Investment
PledgedAssetsSeparatelyReportedMortgageRelatedSecuritiesAvailableForSaleOrHeldForInvestment
22858000 USD
CY2020Q4 us-gaap Pledged Assets Separately Reported Mortgage Related Securities Available For Sale Or Held For Investment
PledgedAssetsSeparatelyReportedMortgageRelatedSecuritiesAvailableForSaleOrHeldForInvestment
7529000 USD
CY2021Q3 us-gaap Escrow Deposit
EscrowDeposit
121394000 USD
CY2020Q4 us-gaap Escrow Deposit
EscrowDeposit
1494000 USD
CY2021Q3 us-gaap Inventory Real Estate
InventoryRealEstate
6268081000 USD
CY2020Q4 us-gaap Inventory Real Estate
InventoryRealEstate
465936000 USD
CY2021Q3 open Other Assets Current Fair Value Disclosure
OtherAssetsCurrentFairValueDisclosure
616000 USD
CY2020Q4 open Other Assets Current Fair Value Disclosure
OtherAssetsCurrentFairValueDisclosure
373000 USD
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
84365000 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
24987000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
8821000000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
2053111000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
38321000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29228000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
43800000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
49517000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
47158000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
30945000 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11494000 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
8684000 USD
CY2021Q3 open Other Assets Noncurrent Fair Value Disclosure
OtherAssetsNoncurrentFairValueDisclosure
5100000 USD
CY2020Q4 open Other Assets Noncurrent Fair Value Disclosure
OtherAssetsNoncurrentFairValueDisclosure
0 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6842000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4097000 USD
CY2021Q3 us-gaap Assets
Assets
8968615000 USD
CY2020Q4 us-gaap Assets
Assets
2175582000 USD
CY2021Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
156030000 USD
CY2020Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
25270000 USD
CY2021Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
4049812000 USD
CY2020Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
339173000 USD
CY2021Q3 us-gaap Secured Debt Current
SecuredDebtCurrent
19728000 USD
CY2020Q4 us-gaap Secured Debt Current
SecuredDebtCurrent
7149000 USD
CY2021Q3 us-gaap Interest Payable Current
InterestPayableCurrent
9746000 USD
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1081000 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4637000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
20716000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4239953000 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
393389000 USD
CY2021Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
1367989000 USD
CY2020Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
135467000 USD
CY2021Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
952415000 USD
CY2020Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 USD
CY2021Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0 USD
CY2020Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
47349000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
43073000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
46625000 USD
CY2021Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2324000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
94000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
6605754000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
622924000 USD
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
607215233 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
607215233 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
540714692 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
540714692 shares
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
60000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
54000 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3877418000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2596012000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1514509000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1043449000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-108000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
41000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2362861000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1552658000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8968615000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2175582000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2266354000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
338613000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4199014000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2334235000 USD
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
2063865000 USD
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
302802000 USD
us-gaap Cost Of Revenue
CostOfRevenue
3740622000 USD
us-gaap Cost Of Revenue
CostOfRevenue
2152803000 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
202489000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
35811000 USD
us-gaap Gross Profit
GrossProfit
458392000 USD
us-gaap Gross Profit
GrossProfit
181432000 USD
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
153496000 USD
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
27336000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
319087000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
156290000 USD
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
90105000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
40168000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
502800000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
99074000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
27295000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13184000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
102360000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
45809000 USD
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
270896000 USD
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
80688000 USD
us-gaap Operating Expenses
OperatingExpenses
924247000 USD
us-gaap Operating Expenses
OperatingExpenses
301173000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-68407000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-44877000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-465855000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-119741000 USD
CY2021Q3 open Fair Value Adjustment Of Warrants And Derivative Liabilities
FairValueAdjustmentOfWarrantsAndDerivativeLiabilities
-3499000 USD
CY2020Q3 open Fair Value Adjustment Of Warrants And Derivative Liabilities
FairValueAdjustmentOfWarrantsAndDerivativeLiabilities
24329000 USD
open Fair Value Adjustment Of Warrants And Derivative Liabilities
FairValueAdjustmentOfWarrantsAndDerivativeLiabilities
-12179000 USD
open Fair Value Adjustment Of Warrants And Derivative Liabilities
FairValueAdjustmentOfWarrantsAndDerivativeLiabilities
25219000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
43550000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
12376000 USD
us-gaap Interest Expense
InterestExpense
70375000 USD
us-gaap Interest Expense
InterestExpense
57393000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
51965000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
764000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
53601000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3619000 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-56493000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-80818000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-470450000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-198734000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
326000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
35000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
610000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
234000 USD
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-56819000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-80853000 USD
us-gaap Profit Loss
ProfitLoss
-471060000 USD
us-gaap Profit Loss
ProfitLoss
-198968000 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.91
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.80
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.32
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.91
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.80
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.32
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
603389000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89070000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
585854000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85907000 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
603389000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
89070000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
585854000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85907000 shares
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-56819000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-80853000 USD
us-gaap Profit Loss
ProfitLoss
-471060000 USD
us-gaap Profit Loss
ProfitLoss
-198968000 USD
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-106000 USD
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-158000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-147000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
126000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-56927000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-81011000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-471209000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-198842000 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2417921000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
51772000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4532000 USD
CY2021Q3 open Adjustments To Additional Paid In Capital Purchase Of Options Indexed To Issuers Equity
AdjustmentsToAdditionalPaidInCapitalPurchaseOfOptionsIndexedToIssuersEquity
118766000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
64318000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-108000 USD
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-56819000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2362861000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1552658000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
857194000 USD
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
57573000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11269000 USD
open Adjustments To Additional Paid In Capital Purchase Of Options Indexed To Issuers Equity
AdjustmentsToAdditionalPaidInCapitalPurchaseOfOptionsIndexedToIssuersEquity
118766000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
474085000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-149000 USD
us-gaap Profit Loss
ProfitLoss
-471060000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2362861000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-843519000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
21000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
397000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2522000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-158000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-80853000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-708650000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-733103000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
95000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1098000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9162000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
126000 USD
us-gaap Profit Loss
ProfitLoss
-198968000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-708650000 USD
us-gaap Profit Loss
ProfitLoss
-471060000 USD
us-gaap Profit Loss
ProfitLoss
-198968000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
26551000 USD
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
31114000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
6055000 USD
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
22008000 USD
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
3227000 USD
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
465059000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
9162000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-12179000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1901000 USD
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
5237000 USD
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
0 USD
us-gaap Inventory Write Down
InventoryWriteDown
32602000 USD
us-gaap Inventory Write Down
InventoryWriteDown
7517000 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
243000 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-22568000 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
51013000 USD
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
0 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
3910000 USD
open Dividend In Kind
DividendInKind
264000 USD
open Dividend In Kind
DividendInKind
0 USD
open Net Fair Value Adjustments And Gain Loss On Sale Of Mortgage Loans Held For Sale
NetFairValueAdjustmentsAndGainLossOnSaleOfMortgageLoansHeldForSale
3144000 USD
open Net Fair Value Adjustments And Gain Loss On Sale Of Mortgage Loans Held For Sale
NetFairValueAdjustmentsAndGainLossOnSaleOfMortgageLoansHeldForSale
2131000 USD
us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
153789000 USD
us-gaap Payments For Origination And Purchases Of Loans Held For Sale
PaymentsForOriginationAndPurchasesOfLoansHeldForSale
88098000 USD
us-gaap Proceeds From Sale And Collection Of Loans Heldforsale
ProceedsFromSaleAndCollectionOfLoansHeldforsale
141624000 USD
us-gaap Proceeds From Sale And Collection Of Loans Heldforsale
ProceedsFromSaleAndCollectionOfLoansHeldforsale
78360000 USD
open Increase Decrease In Escrow Receivable
IncreaseDecreaseInEscrowReceivable
119900000 USD
open Increase Decrease In Escrow Receivable
IncreaseDecreaseInEscrowReceivable
-11241000 USD
us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
5805802000 USD
us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
-1146798000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
50202000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-793000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
102310000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3355000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
3183000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-2530000 USD
open Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-11864000 USD
open Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-9646000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5903558000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1037354000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22878000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12068000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
790000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
458585000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
174530000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
85638000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
135778000 USD
open Payments To Acquire Equity Securities Fvni
PaymentsToAcquireEquitySecuritiesFVNI
15100000 USD
open Payments To Acquire Equity Securities Fvni
PaymentsToAcquireEquitySecuritiesFVNI
0 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
20110000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-431825000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-50820000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
953066000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
open Payments For Option Indexed To Issuers Equity
PaymentsForOptionIndexedToIssuersEquity
118766000 USD
open Payments For Option Indexed To Issuers Equity
PaymentsForOptionIndexedToIssuersEquity
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
11268000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1078000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
22402000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
886067000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
28876000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
7782076000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
912082000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
2837436000 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
1949165000 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
150748000 USD
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
85996000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
138169000 USD
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
74720000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
9274000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
3068000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1505528000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
684822000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6673106000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1027797000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
337723000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-41263000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1843251000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
643559000 USD
us-gaap Interest Paid Net
InterestPaidNet
57151000 USD
us-gaap Interest Paid Net
InterestPaidNet
47977000 USD
open Issuance Of Issuer Stock Rights In Extinguishment Of Convertible Notes
IssuanceOfIssuerStockRightsInExtinguishmentOfConvertibleNotes
0 USD
open Issuance Of Issuer Stock Rights In Extinguishment Of Convertible Notes
IssuanceOfIssuerStockRightsInExtinguishmentOfConvertibleNotes
212940000 USD
us-gaap Stock Issued1
StockIssued1
35170000 USD
us-gaap Stock Issued1
StockIssued1
0 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1358775000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
469365000 USD
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
484476000 USD
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
174194000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1843251000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
643559000 USD
CY2020Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
47349000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
622924000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2596012000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1043449000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1552658000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ materially from such estimates. Significant estimates, assumptions and judgments made by management include, among others, the determination of the fair value of common stock, share-based awards, warrants, derivatives, convertible senior notes, and inventory impairment (“real estate inventory valuation adjustment”). Management believes that the estimates and judgments upon which they rely are reasonable based upon information available to them at the time that these estimates and judgments are made. To the extent that there are material differences between these estimates and actual results, the Company’s financial statements will be affected. The COVID-19 pandemic introduced significant additional uncertainties with respect to estimates, judgments and assumptions, which may materially impact these estimates.</span></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, investments in marketable securities, and mortgage loans held for sale pledged under agreements to repurchase (“MLHFS”). The Company places cash and cash equivalents and investments with major financial institutions, which management assesses to be of high credit quality, in order to limit exposure of the Company’s investments.</span></div>Similarly, the Company’s credit risk on mortgage loans held for sale is mitigated due to a large number of customers. Further, the Company’s credit risk on mortgage loans held for sale is mitigated by the fact that the Company typically sells mortgages on the secondary market within a relatively short period of time after which the Company’s exposure is limited to borrower defaults within the initial few months of the mortgage.
CY2021Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
700000 USD
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
4200000 USD
CY2020Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
1800000 USD
CY2021Q3 open Class Of Warrant Or Right Redemption Price
ClassOfWarrantOrRightRedemptionPrice
0.10
CY2020Q4 open Business Combination Consideration Transferred Stock Issued Conversion Ratio
BusinessCombinationConsiderationTransferredStockIssuedConversionRatio
1
CY2021Q3 us-gaap Inventory Real Estate Construction In Process
InventoryRealEstateConstructionInProcess
2759984000 USD
CY2020Q4 us-gaap Inventory Real Estate Construction In Process
InventoryRealEstateConstructionInProcess
183004000 USD
CY2021Q3 open Inventory Real Estate Finished Goods
InventoryRealEstateFinishedGoods
3508097000 USD
CY2020Q4 open Inventory Real Estate Finished Goods
InventoryRealEstateFinishedGoods
282932000 USD
CY2021Q3 us-gaap Inventory Real Estate
InventoryRealEstate
6268081000 USD
CY2020Q4 us-gaap Inventory Real Estate
InventoryRealEstate
465936000 USD
CY2021Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
61013000 USD
CY2021Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
61013000 USD
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
17000 USD
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
123000 USD
CY2021Q3 open Equity Securities Fvni Cash And Cash Equivalents
EquitySecuritiesFVNICashAndCashEquivalents
0 USD
CY2021Q3 open Equity Securities Fvni Marketable Securities
EquitySecuritiesFVNIMarketableSecurities
61013000 USD
CY2021Q3 open Cash Cash Equivalents And Marketable Securities Amortized Cost
CashCashEquivalentsAndMarketableSecuritiesAmortizedCost
1839932000 USD
CY2021Q3 open Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
1839826000 USD
CY2021Q3 open Marketable Securities Cash And Cash Equivalents
MarketableSecuritiesCashAndCashEquivalents
1358775000 USD
CY2021Q3 us-gaap Marketable Securities
MarketableSecurities
481051000 USD
CY2020Q4 open Cash Cash Equivalents And Marketable Securities Amortized Cost
CashCashEquivalentsAndMarketableSecuritiesAmortizedCost
1460260000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
48000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
6000 USD
CY2020Q4 open Cash Cash Equivalents And Marketable Securities
CashCashEquivalentsAndMarketableSecurities
1460302000 USD
CY2020Q4 open Marketable Securities Cash And Cash Equivalents
MarketableSecuritiesCashAndCashEquivalents
1412665000 USD
CY2020Q4 us-gaap Marketable Securities
MarketableSecurities
47637000 USD
CY2021Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
188741000 USD
CY2021Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
123000 USD
CY2021Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 USD
CY2021Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
CY2021Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
188741000 USD
CY2021Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
123000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
31445000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
6000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
0 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
31445000 USD
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
6000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
219774000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
69662000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
150112000 USD
CY2021Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
5100000 USD
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
0 USD
CY2021Q3 open Option Indexed To Issuers Equity Cap Price Premium
OptionIndexedToIssuersEquityCapPricePremium
1
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
88190000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
63486000 USD
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
49869000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
34258000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
38321000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29228000 USD
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7200000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
18900000 USD
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6100000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
17000000 USD
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
16200000 USD
CY2020 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
20811000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9471000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11340000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
15821000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
7295000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
8526000 USD
CY2021Q3 us-gaap Indefinite Lived Trade Names
IndefiniteLivedTradeNames
200000 USD
CY2020Q4 us-gaap Indefinite Lived Trade Names
IndefiniteLivedTradeNames
200000 USD
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2200000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
900000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3100000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1838000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
5616000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2320000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1566000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
3000 shares
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
11340000 USD
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
24158000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.91
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y4M24D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
502767000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
150000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
15.00
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6791000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.68
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
774000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.84
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y9M18D
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
3.02
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
16740000 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.05
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
309327000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
14386000 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.70
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y4M24D
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
270848000 USD
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
62011000 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2522000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
465059000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9162000 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
15.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.73
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0109
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1 shares
CY2020Q2 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2021Q3 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
22400000 USD
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0004
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0012
open Class Of Warrants And Rights Redemption Price Per Share
ClassOfWarrantsAndRightsRedemptionPricePerShare
0.01
CY2021Q3 open Class Of Warrant Or Right Reference Value
ClassOfWarrantOrRightReferenceValue
18.00
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2021Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
19933333 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3500000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-12200000 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
600000 USD
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0058
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0017
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30000.00 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
230000 USD
us-gaap Dividends
Dividends
0 USD
CY2021Q3 us-gaap Dividends
Dividends
0 USD
CY2020Q3 us-gaap Dividends
Dividends
0 USD
us-gaap Dividends
Dividends
0 USD
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-56819000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-80853000 USD
us-gaap Profit Loss
ProfitLoss
-471060000 USD
us-gaap Profit Loss
ProfitLoss
-198968000 USD
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
603389000 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
603389000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
89070000 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89070000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
585854000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
585854000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85907000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85907000 shares
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.91
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.91
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.80
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.80
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.32
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.32
CY2021Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 USD
us-gaap Dividends Preferred Stock
DividendsPreferredStock
0 USD
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
74369000 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
383266000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
74369000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
383266000 shares
CY2021Q3 us-gaap Recorded Unconditional Purchase Obligation Minimum Quantity Required
RecordedUnconditionalPurchaseObligationMinimumQuantityRequired
6231 home
CY2021Q3 us-gaap Recorded Unconditional Purchase Obligation
RecordedUnconditionalPurchaseObligation
2259900000 USD
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
5200000 USD

Files In Submission

Name View Source Status
0001801169-21-000120-index-headers.html Edgar Link pending
0001801169-21-000120-index.html Edgar Link pending
0001801169-21-000120.txt Edgar Link pending
0001801169-21-000120-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
open-20210930.htm Edgar Link pending
open-20210930.xsd Edgar Link pending
open-20210930_cal.xml Edgar Link unprocessable
open-20210930_def.xml Edgar Link unprocessable
open-20210930_htm.xml Edgar Link completed
open-20210930_lab.xml Edgar Link unprocessable
open-20210930_pre.xml Edgar Link unprocessable
q32021ex101formofoptionagr.htm Edgar Link pending
q32021exhibit311.htm Edgar Link pending
q32021exhibit312.htm Edgar Link pending
q32021exhibit321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending